Mycronic AB (MYCR) AI Stock Analysis

• Market Cap: kr43.85B
• Dividend Yield: 1.23%
• Average Volume (3M): 202.03K
• Price to Earnings (P/E): 22.1
• Beta (1Y): 1.06
• Revenue Growth: 24.55%
• EPS Growth: 32.41%
• Country: SE
• Employees: 2,318
• Sector: Technology
• Sector Strength: 88
• Industry: Industrial - Machinery
• EPS (TTM): 2.28
• Shares Outstanding: 195,833,020
• 10 Day Avg. Volume: 303,612
• 30 Day Avg. Volume: 202,032
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: kr218.00
• Price Target Upside: 11.22% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 72 Outperform
• Price Target: kr218.00 ▲(11.22% Upside)

Mycronic AB's strong financial performance is the most significant factor, supported by robust revenue growth and a solid balance sheet. However, technical analysis indicates a bearish trend, and valuation metrics suggest the stock is fairly valued. The absence of earnings call data and corporate events does not impact the score.

Mycronic AB Business Overview & Revenue Model

Company Description

Mycronic AB (publ), together with its subsidiaries, develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. The company operates through four segments: Pattern Generators, High Flex, High Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers and measuring machines for production of advanced photomasks for manufacturing of screens for TVs, cars, mobile phones, tablets, and computers, as well as the semiconductor components. The High Flex segment develops, manufactures, and markets surface mount technology (SMT) and inspection equipment for flexible printed circuit board (PCBs) assembly. This segment offers MYPro Line, which integrates advanced jet printing and dispensing, pick-and-place, advanced process control solutions, and 3D inspection systems; MYTower material handling systems; and MYSmart dispensing and coating solutions. The High Volume segment develops, manufactures, and markets equipment for dispensing and conformal coating of circuit boards for manufacturers of mobile phones, tablets, computers, and electronics for electric vehicles, as well as automated screen printers. The Global Technologies segment offers die-bonding services for microelectronics and optoelectronic applications; advanced electrical measurement of bare board PCBs and substrates; flying probe test system, an automated electrical measurement system for low to mid quantities and complex boards; and grid test systems for volume bare board verification. It sells its products through agents and distributors. The company serves industrial, aerospace, defense, automotive, energy, medical, and telecom sectors. The company was formerly known as Micronic Mydata AB (publ) and changed its name to Mycronic AB (publ) in June 2014. Mycronic AB (publ) is headquartered in Täby, Sweden.

How the Company Makes Money

Mycronic generates revenue through a combination of product sales, service agreements, and software solutions. The company's primary revenue stream comes from the sale of its high-tech assembly equipment, which is in demand due to the growth of the electronics market. Additionally, Mycronic earns income from maintenance and support services for its machines, ensuring ongoing customer engagement and revenue stability. The company also benefits from software sales that enhance the functionality of its hardware. Strategic partnerships with major players in the electronics and semiconductor industries further bolster its revenue potential, as these collaborations can lead to increased sales and shared technological advancements.

Mycronic AB Financial Statement Overview

Summary

Mycronic AB shows strong financial health with impressive revenue growth, robust profit margins, and a solid balance sheet with low leverage. However, a decline in free cash flow needs attention.

Income Statement

Mycronic AB shows strong revenue growth with a 31.54% increase from 2023 to TTM. The gross profit margin is robust at 54.0% TTM, indicating effective cost management. Net profit margin improved to 24.2%, suggesting enhanced profitability. EBIT and EBITDA margins are solid at 29.8% and 29.9% respectively, indicating efficient operations. Overall, the income statement reflects healthy growth and profitability.

Balance Sheet

The company maintains a strong balance sheet with a low debt-to-equity ratio of 0.03, demonstrating conservative leverage. Return on equity is impressive at 25.7%, indicating efficient use of equity to generate profits. The equity ratio of 67.1% reflects a solid capital structure and financial stability. The balance sheet suggests low financial risk and strong shareholder value.

Cash Flow

Operating cash flow to net income ratio is healthy at 0.76, showing reliable cash generation from operations. However, free cash flow decreased by 17.8% from 2024 to TTM, primarily due to reduced operating cash flow. Despite this, the free cash flow to net income ratio remains strong at 0.74, indicating good cash conversion. Overall, cash flow performance is robust but shows slight pressure from declining free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	8.05B	7.06B	5.71B	5.12B	4.63B	3.88B
Gross Profit	4.38B	3.72B	2.72B	2.29B	2.28B	2.08B
EBITDA	2.54B	2.32B	1.39B	1.11B	1.15B	1.06B
Net Income	1.97B	1.68B	998.00M	741.00M	828.00M	694.00M
Balance Sheet
Total Assets	10.35B	10.41B	8.34B	7.34B	6.14B	5.32B
Cash, Cash Equivalents and Short-Term Investments	1.80B	3.01B	2.14B	1.27B	683.00M	1.30B
Total Debt	197.00M	219.00M	228.00M	270.00M	243.00M	264.00M
Total Liabilities	3.57B	3.84B	3.06B	2.64B	2.14B	1.94B
Stockholders Equity	6.74B	6.53B	5.25B	4.66B	3.96B	3.36B
Cash Flow
Free Cash Flow	995.00M	1.64B	1.41B	712.00M	908.00M	991.00M
Operating Cash Flow	1.42B	1.87B	1.61B	853.00M	998.00M	1.13B
Investing Cash Flow	-1.23B	-500.00M	-195.00M	67.00M	-1.22B	-150.00M
Financing Cash Flow	-848.00M	-552.00M	-447.00M	-382.00M	-437.00M	-288.00M

Mycronic AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 196.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:MYCR, the sentiment is Negative. The current price of 196 is below the 20-day moving average (MA) of 217.71, below the 50-day MA of 214.29, and below the 200-day MA of 207.63, indicating a bearish trend. The MACD of 0.06 indicates Positive momentum. The RSI at 32.73 is Neutral, neither overbought nor oversold. The STOCH value of 58.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:MYCR.

Mycronic AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ATCO.B	78 Outperform	kr788.23B	25.87	28.28%	1.98%	-2.31%	-4.41%
SAND	76 Outperform	kr337.30B	23.28	16.41%	2.14%	-1.82%	12.60%
MYCR	72 Outperform	kr43.85B	22.14	31.98%	1.23%	24.55%	32.41%
ALFA	72 Outperform	kr185.50B	23.11	20.37%	1.90%	2.66%	19.90%
ATCO.A	71 Outperform	kr788.23B	29.13	28.28%	1.76%	-2.31%	-4.41%
TREL.B	64 Neutral	kr79.85B	23.09	9.31%	2.13%	2.42%	4.02%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%

Mycronic AB Corporate Events

Mycronic AB Reports Strong Q2 Sales Growth and Strategic Acquisitions

Mycronic AB reported a 35% increase in net sales for the second quarter of 2025, driven by strong growth in Pattern Generators, High Volume, and Global Technologies, despite a 37% decline in order intake. The company completed acquisitions of RoBAT and Surfx Technologies, enhancing its capabilities in PCB testing and surface treatment solutions. The outlook for 2025 has been revised upward, reflecting confidence in achieving higher net sales, supported by a strong performance in the Chinese market and strategic expansions.

Mycronic Expands in South Korea with Cowin DST Acquisition

Mycronic’s Pattern Generators division has agreed to acquire Cowin DST, a South Korean company specializing in display panel and photomask repair systems. This acquisition will enhance Mycronic’s product offerings and strengthen its presence in South Korea, a key market for semiconductors and displays, while opening new market opportunities and improving customer solutions.

Mycronic AB to Present Q2 2025 Financial Results

Mycronic AB has announced an upcoming presentation for its Q2 2025 financial results, scheduled for July 11, 2025. The presentation will be led by the company’s President and CEO, Anders Lindqvist, and CFO, Pierre Brorsson, with a webcast available for analysts, investors, and media. This event is significant for stakeholders as it provides insights into the company’s financial health and strategic direction.